Christina H Yeon

Summary

Publications

  1. ncbi request reprint Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer
    Christina H Yeon
    Division of Hematology Oncology and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA
    Invest New Drugs 23:391-409. 2005

Collaborators

Detail Information

Publications1

  1. ncbi request reprint Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer
    Christina H Yeon
    Division of Hematology Oncology and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA
    Invest New Drugs 23:391-409. 2005
    ..Current clinical investigations of trastuzumab include its use in both the adjuvant and neoadjuvant settings as well as in combination with other chemotherapy drugs or new biologic targeted agents...